Effects of Immediate and Delayed Repeated Cold Exposure After Physical Exertion
Launched by UNIVERSITY OF APPLIED SCIENCES AND ARTS OF SOUTHERN SWITZERLAND · Feb 6, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether using cold therapy can help reduce muscle soreness, swelling, and pain after physical activity. Specifically, it aims to find out if applying cold packs can make a difference for adults who experience Delayed Onset Muscle Soreness (DOMS) after exercise. Participants will engage in physical activities that are expected to cause muscle soreness and then use a special cold pack on the affected areas. They will report their experiences with pain, stiffness, and swelling over the next three days to see if the cold therapy helps them recover faster.
To take part in this study, participants need to be healthy adults aged 18 to 30 years and should not have had any recent surgeries on their lower body. There are some exclusions for those with current pain or inflammatory conditions, certain medical issues, or who are pregnant. This trial is not yet recruiting participants, but it aims to provide valuable information on how effective cold therapy can be for muscle recovery and pain relief.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Young, healthy adults aged between 18 and 30 years
- • No surgical interventions on the musculoskeletal system in the trunk area or lower extremities
- • Exclusion Criteria
- • Current pain conditions
- • Current inflammatory conditions
- • Medication use (excluding contraceptives)
- • Pregnant participants
- • Competitive athletes
- • Children/teenagers
- • Non-intact skin conditions (e.g., psoriasis)
- • Known circulatory disorders
- • Cold allergy (Raynaud's disease)
About University Of Applied Sciences And Arts Of Southern Switzerland
The University of Applied Sciences and Arts of Southern Switzerland (SUPSI) is a leading academic institution dedicated to fostering innovation and applied research across various disciplines. With a strong emphasis on interdisciplinary collaboration, SUPSI engages in clinical trials that aim to advance healthcare practices and improve patient outcomes. The university leverages its expertise in technology, health sciences, and social work to develop evidence-based solutions that address contemporary challenges in the medical field. Through partnerships with industry stakeholders and healthcare providers, SUPSI is committed to translating research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ron Clijsen, Prof. Dr.
Principal Investigator
University of Applied Sciences of Southern Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported